Extensive insurer claim denials and administrative hurdles impose a substantial time tax on U.S. healthcare consumers, affecting productivity and trust in health systems. Employer accountability and regulatory gaps remain critical issues.

CMS accelerates Medicare price negotiations for drugs with hyaluronidase, impacting biologic drug pricing and pharmaceutical companies like Halozyme Therapeutics and Johnson & Johnson.

CMS issued final rules and updates for Medicare Advantage and Part D programs for 2026, including Inflation Reduction Act implementations and inpatient care protections.

President Trump signs an executive order setting a 30-day deadline for drugmakers to lower prescription drug prices in the U.S. or face new federal limits tied to international prices.

Wolf Haldenstein law firm investigates data breach claims affecting American Income Life Insurance policyholders, highlighting cybersecurity and compliance issues in insurance.

The NY Department of Financial Services reiterates rigorous, consistent standards for licensing financial institutions, emphasizing compliance and consumer protection for insurers and financial firms.

Arkansas submits ARHOME Medicaid expansion renewal with revised work requirements and legislative Act 774 aims for $260M+ taxpayer savings.

A loophole in the Affordable Care Act has led to the sales of low-cost health insurance plans by a former sitcom writer, raising concerns about coverage adequacy and regulatory compliance in the U.S. health insurance market.

State Farm's valuation of totaled vehicles faces legal scrutiny in a Supreme Court case that could reshape insurance payout transparency and policyholder protections.

Republicans in Congress seek to implement trillion-dollar Medicaid reforms through reconciliation, targeting waste, fraud, and abuse while expanding tax cuts and curbing federal spending growth.